Lilly is aiming to strengthen its position as a leader in the obesity treatment market, which is expected to hit $150 billion ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Hi, it's Amber in Hong Kong. Blockbuster weight-loss drug Wegovy is going to be much cheaper in China than it is in the US.

This investor's weighing up a couple of world-class companies for his Stocks and Shares ISA after the US election sparked a sell-off.

European mega-caps trail US 'Magnificent Seven' amid lack of artificial intelligence gains, while also facing China's ...

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...

The Bank of England said retailers were right to warn of job cuts UK inflation accelerated sharply back up to 2.3% in October ...

The newspapers are full of colourful accounts of yesterday's protests in which 13,000 farmers took to the streets of ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

The first European company is in 25th place – Denmark’s Novo Nordisk, famed for its manufacture of Ozempic and Wegovy, and ...

China has recovered slightly from last year ... Earlier in November, Novo Nordisk's Wegovy weight-loss drug sales beat its ...